InsidersTradesSigma
Xvivo Perfusion Aktiebolag: directors' dealings · Finland · FIN-FSA
FI:xvivo-perfusion-aktiebolag-2919c4SE0004840718FI·FIN-FSAMcap 8.9Bn€Healthcare
Explore the full insider trade history of Xvivo Perfusion Aktiebolag, a listed equity based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Xvivo Perfusion Aktiebolag has published 1 public disclosures. Market capitalisation: €8.9bn. The latest transaction was reported on 18 November 2025 (Purchase). Among the most active insiders: Lena Hagman. The full history is openly available.
1
Insider Decl.
0
Thresholds
€21,972
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
284.00 €
Analyst consensus
5 analystsStrong buy
300.00 €Target 337.00 €(+19%)385.00 €
Income statement
Revenue812.2 M€
Gross profit599.5 M€74% margin
Net income25.2 M€8.9% margin
Valuation
PER (trailing)121.4x
PER (forward)41.4x
P/Book4.2x
Beta1.42
Balance sheet & cash
Market cap8.95 Bn€
Total debt124.7 M€
Free Cash Flow−151.8 M€
Debt / Equity6%
Profitability & ownership
ROE3.5%
ROA2.6%
% insiders7.8%
% institutions60.0%
Last declaration on 18 November 2025
Declarations1 total
Executives●Purchase35FIN-FSA
€21,9721,500 shares@ €14.64830.0002% mcap100.0% of flow
Aktie
FI:A003T743-1·
Ideal exit: 15 Aug 2026 (T+270)
1 of 1 declaration